Status:
COMPLETED
Dipeptidyl Peptidase-4 Link With Oral Cancer and Premalignant Lesions
Lead Sponsor:
Fayoum University
Conditions:
Oral Premalignant Lesions as Leukoplakia and Lichen Planus
Oral Cancer
Eligibility:
All Genders
30-65 years
Brief Summary
Aim: The current study targets linking serum and salivary dipeptidyl peptidase-4 with oral squamous cell carcinoma and comparing it with potentially malignant lesions and control to validate dipeptidy...
Eligibility Criteria
Inclusion
- systemically healthy
- No current medication,
- both genders with age ranging from 30 to 65 years old.
- having oral leukoplakia, oral lichen planus or oral squamous cell carcinoma
Exclusion
- systemic disease
- pregnancy
- lactation
- being diagnosed with any other oral mucosal lesion
Key Trial Info
Start Date :
August 15 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2023
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT06087042
Start Date
August 15 2023
End Date
October 1 2023
Last Update
October 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
faculty of dentistry, Fayoum university
Al Fayyum, Egypt